The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Clinical outcomes following “off-label” versus “established” indications of bioresorbable scaffolds for the treatment of coronary artery disease in a real-world population

EuroIntervention 2016;11:1475-1478. DOI: 10.4244/EIJV11I13A286

1. Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy; 2. Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy; 3. Department of Cardiovascular Medicine, Juntendo University, Tokyo, Japan; 4. Imperial Co

Aims: Our aim was to investigate one-year outcomes in patients treated with bioresorbable scaffolds (BRS) for “off-label” versus currently “established” indications.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
A novel approach to treat in-stent restenosis: 6- and 12-month results using the everolimus-eluting bioresorbable vascular scaffold